Related references
Note: Only part of the references are listed.
Article
Biochemistry & Molecular Biology
Pei-Pei Zhang et al.
Summary: Severe neurological symptoms and pathological changes were observed in the brains of critically ill COVID-19 patients. The study revealed neurophagocytosis, microglia nodules, blood-brain barrier damage, and infiltration of mononuclear cells in the brains of COVID-19 patients. Upregulated proteins involved in immune responses and cellular metabolism, and downregulated proteins related to brain development and neuroprotection were identified. These findings provide insights into the pathogenesis of COVID-19-associated monocytic encephalitis (CAME) and suggest potential therapeutic targets.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2023)
Article
Biochemistry & Molecular Biology
Sam Afkhami et al.
Summary: The study found that using adenoviral vectors with a multivalent vaccine through intranasal immunization can generate better mucosal immune responses, including local and systemic antibody responses, mucosal tissue-resident memory T cells, and mucosal trained innate immunity, and provide protection against multiple viral variants.
Article
Immunology
Tianyang Mao et al.
Summary: The antiviral capacity of the minimal RIG-I agonist SLR14 was assessed in mouse models of SARSCoV-2 infection. The study found that SLR14 could prevent viral infection, treat infected mice, and provide cross-variant protection, even in immunodeficient mice.
JOURNAL OF EXPERIMENTAL MEDICINE
(2022)
Article
Virology
Emma S. Winkler et al.
Summary: The study developed a mouse model for SARS-CoV-2 infection by introducing the human ACE2 gene into the mouse genome, providing insights into viral replication and pathology in mice. Additionally, the study identified the impact of the N501Y mutation in mice on viral replication and pathogenesis.
JOURNAL OF VIROLOGY
(2022)
Article
Multidisciplinary Sciences
Peter J. Halfmann et al.
Summary: The recent study by the SAVE/NIAID network shows that the B.1.1.529 Omicron variant causes milder lung disease in rodents, which is consistent with preliminary human clinical data.
Article
Multidisciplinary Sciences
Leo Swadling et al.
Summary: Research suggests that some individuals can clear potential SARS-CoV-2 infection after exposure, with T cells playing a role in the process. Studying healthcare workers who tested negative for antibodies revealed that they had stronger and more diverse memory T cells, with a focus on RTC.
Review
Cell Biology
Cody B. Jackson et al.
Summary: The entry of SARS-CoV-2 into host cells is facilitated by the interaction between the viral spike protein and ACE2, leading to virus-cell membrane fusion, which has been extensively studied at the structural and cellular levels worldwide. This understanding has paved the way for the development of effective vaccines in response to the COVID-19 pandemic, caused by the infection with SARS-CoV-2.
NATURE REVIEWS MOLECULAR CELL BIOLOGY
(2022)
Article
Pathology
Enric Vidal et al.
Summary: This study chronologically characterized the neuroinvasion and neuropathology of SARS-CoV-2 in a mouse model. The virus was found to enter the brain early through the olfactory mucosa and rapidly spread between neurons, causing acute encephalitis and neuronal damage.
VETERINARY PATHOLOGY
(2022)
Article
Immunology
Valeria Fumagalli et al.
Summary: In this study, researchers described a method using an inhalation tower system to expose unanesthetized transgenic mice to aerosolized virus. This approach has advantages in simulating COVID-19 pathogenesis and provides a useful tool for studying viral transmission, disease pathogenesis, and therapeutic interventions.
SCIENCE IMMUNOLOGY
(2022)
Article
Critical Care Medicine
Neha S. Dangayach et al.
CRITICAL CARE CLINICS
(2022)
Article
Multidisciplinary Sciences
Esen Sefik et al.
Summary: This study demonstrates that lung-resident human macrophages play a critical role in the development of lung inflammation caused by SARS-CoV-2 infection. Macrophages activate inflammasomes, release inflammatory cytokines, and undergo pyroptosis in response to infection, contributing to the hyperinflammatory state in the lungs. Inhibition of the NLRP3 inflammasome pathway reverses chronic lung pathology, indicating the importance of inflammasome activation in lung inflammation.
Article
Multidisciplinary Sciences
Paul Elliott et al.
Summary: The rapid transmission of the Omicron variant of SARS-CoV-2 has caused a surge in cases worldwide, including in England. The prevalence of infection is increasing, particularly among older age groups, but hospitalizations and deaths remain lower compared to previous waves, likely due to high levels of vaccination.
Article
Virology
Frauke Seehusen et al.
Summary: SARS-CoV-2 not only affects the respiratory tract but also causes neurological symptoms and neuroinflammation. Using transgenic mice, it was found that various SARS-CoV-2 variants can spread to the central nervous system (CNS) following intranasal infection and primarily infect neurons. The inflammatory response is mainly driven by microglia and immune cells, and microglia may play a significant role in the pathology and viral effects of COVID-19.
Article
Virology
Janhavi Prasad Natekar et al.
Summary: This study evaluated the pathogenesis of different variants of SARS-CoV-2 in mice expressing human ACE-2. The B.1.1.7, B.1.351, and B.1.617.2 variants were found to be more lethal and resulted in higher viral titers in the lungs and brain compared to the original B.1 strain. Interestingly, the B.1.1.529 variant showed less severe clinical signs and higher survival rates. Transcription levels of cytokines and chemokines were lower in mice infected with B.1 and B.1.1.529 compared to other variants.
Article
Multidisciplinary Sciences
Ibolya Rutkai et al.
Summary: COVID-19 infection can lead to neurological manifestations, and animal models can provide insights into the underlying mechanisms. In this study, neuroinflammation, microhemorrhages, and brain hypoxia were observed in SARS-CoV-2 infected non-human primates, even in those without severe respiratory disease. These findings are important for understanding the neuropathogenesis of SARS-CoV-2 infection and may help explain the neurological symptoms associated with long COVID.
NATURE COMMUNICATIONS
(2022)
Article
Cell Biology
Devin J. Kenney et al.
Summary: The study successfully recapitulated human lung immune response using the HNFL mouse model and identified the association between lung tissue protection and macrophage infiltration and differentiation, as well as upregulation of the type I interferon signaling pathway.
Article
Medicine, General & Internal
Sreelekshmy Mohandas et al.
Summary: This study assessed the pathogenicity and immune response of the BA.1.1 sub-lineage of SARS-CoV-2 Omicron variant in hamsters and compared it with Delta variant infection. The findings showed that the disease characteristics of the Omicron (R346K) variant were similar to the Delta variant, but the neutralizing antibodies produced against the Omicron (R346K) variant had poor neutralizing ability against other co-circulating SARS-CoV-2 variants.
Article
Neurosciences
Mona Khan et al.
Summary: The study investigated the possibility of SARS-CoV-2 invading the brain through the olfactory projection. The researchers obtained tissue and fluid samples from deceased COVID-19 patients and found no evidence of viral invasion in the olfactory bulb and frontal lobe. Instead, they identified anatomical barriers between the olfactory epithelium and the olfactory nerve.
Article
Microbiology
Tyler N. Starr et al.
Summary: SARS-CoV-2 virus continues to undergo mutations in the spike receptor-binding domain, affecting biochemical properties related to ACE2 receptor binding, folding stability, and antibody recognition. This study investigates the effects of these mutations in the Omicron BA.1 and BA.2 variants, showing potential changes in function compared to the ancestral strain. The research highlights the importance of ongoing surveillance and understanding the mutational landscape for effective monitoring and control of the virus.
Article
Neurosciences
Lindsey Wang et al.
Summary: This retrospective cohort study found that COVID-19 infection is associated with an increased risk of Alzheimer's disease, particularly in older adults and women.
JOURNAL OF ALZHEIMERS DISEASE
(2022)
Article
Biochemistry & Molecular Biology
Lilian Gomes de Oliveira et al.
Summary: COVID-19 infection alters the immune metabolism and disrupts the balance of important metabolic molecules and neurotransmitters in astrocytes, which may contribute to neurological impairment observed during the disease.
JOURNAL OF NEUROCHEMISTRY
(2022)
Article
Clinical Neurology
Geidy E. Serrano et al.
Summary: Brains of 42 COVID-19 decedents and 107 non-COVID-19 controls were studied. SARS-CoV-2 viral sequences were detected in the brains of COVID-19 subjects, suggesting the possible entry of the virus through the olfactory bulb. Gene expression changes related to immune response, neuronal constituents, and olfactory/taste receptor genes were observed in the brains of COVID-19 patients.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
(2022)
Article
Multidisciplinary Sciences
Fernanda Crunfli et al.
Summary: Research indicates that neuropsychiatric dysfunction can occur in individuals with mild COVID-19 infections, and the SARS-CoV-2 virus can infect astrocytes in the brain, leading to neuronal death or dysfunction.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Multidisciplinary Sciences
Federico Armando et al.
Summary: This study compares virus spread and pathology in Syrian golden hamsters infected with different variants of SARS-CoV-2 and finds that the Omicron variant causes milder pathology.
NATURE COMMUNICATIONS
(2022)
Article
Pharmacology & Pharmacy
Weijuan Shang et al.
Summary: FB2001 is a promising therapeutic agent in COVID-19 treatment that exhibits potent antiviral activity against various SARS-CoV-2 variants and shows improvement in pathological symptoms in the lungs and brains. It can be combined with remdesivir for better clinical outcomes. This drug candidate has been approved for Phase II/III clinical trial due to its good safety and tolerability.
ANTIVIRAL RESEARCH
(2022)
Article
Microbiology
Cameron R. Bishop et al.
Summary: The debate on how well mouse models recapitulate the transcriptional profiles seen in humans is ongoing. While there are differences in gene overlap, analyses of immune signatures and inflammatory pathways indicate a significant concordance between species.
Review
Pharmacology & Pharmacy
Daniele Focosi et al.
Summary: The article discusses the impact of WHO-defined SARS-CoV-2 variants of concern on therapeutics and vaccine development, focusing on the Omicron variant and its ability to resist antibody-based therapies. It emphasizes the need for clinicians to explore alternative treatment options.
DRUG RESISTANCE UPDATES
(2022)
Article
Psychiatry
Maxime Taquet et al.
Summary: COVID-19 is associated with increased risks of neurological and psychiatric sequelae. The duration of these risks, their impact on children and adults, and the differences in risk profiles among SARS-CoV-2 variants remain unclear. A 2-year retrospective cohort study analyzed data from electronic health records of COVID-19 patients and found that the risk trajectories differed based on age and outcome. While the risk of mood and anxiety disorders returned to baseline after 1-2 months, the risks of cognitive deficit, dementia, psychotic disorders, and epilepsy or seizures remained increased at the end of the 2-year follow-up period. Children had a more benign overall profile of psychiatric risk but sustained higher risk for certain diagnoses. The findings highlight the importance of understanding the individual and population-level risks of neurological and psychiatric disorders after SARS-CoV-2 infection.
Review
Pathology
Swati Satturwar et al.
Summary: Autopsy findings from COVID-19 and SARS-CoV-1 cases suggest that DAD is more common in SARS-CoV-1, while hepatic necrosis, splenic necrosis, and white pulp depletion are more frequently associated with SARS-CoV-1 compared to COVID-19 cases.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
(2021)
Article
Immunology
Maria Antonella Zingaropoli et al.
Summary: The study revealed that COVID-19 pneumonia patients had higher percentages of NK CD57+ and CD56dim NK cells, but lower percentages of NKT and CD56bright cells in peripheral blood. The severe group showed a significantly lower percentage of NKT cells, with NKT cell independently associated with the severity of the disease. This suggests a potential role of NKT cells in COVID-19 pneumonia.
CLINICAL IMMUNOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Mona Khan et al.
Summary: Anosmia, the loss of smell, is a common symptom of COVID-19, but it is caused by the virus attacking sustentacular cells in the olfactory mucosa rather than infecting olfactory sensory neurons. This suggests that SARS-CoV-2 is not a neurotropic virus.
Article
Immunology
Eric Song et al.
Summary: The study showed through three approaches that SARS-CoV-2 is capable of infecting brain neurons, leading to metabolic changes and pathological features without triggering type I interferon responses. These results provide evidence for the neuroinvasive capacity of SARS-CoV-2 and the unexpected consequence of direct infection of neurons by the virus.
JOURNAL OF EXPERIMENTAL MEDICINE
(2021)
Article
Neurosciences
Jenny Meinhardt et al.
Summary: The study demonstrates the presence of SARS-CoV-2 in the nasopharynx and brain, suggesting the virus may enter the CNS through the olfactory mucosa. The virus utilizes the neural-mucosal interface in the olfactory mucosa to penetrate the nervous system, affecting various neuroanatomical areas, including the primary respiratory and cardiovascular control center.
NATURE NEUROSCIENCE
(2021)
Article
Neurosciences
Elizabeth M. Rhea et al.
Summary: The study demonstrates that the SARS-CoV-2 spike 1 protein can cross the mouse blood-brain barrier and be taken up by both the brain and peripheral tissues. Intravenous injection results in higher levels of protein uptake in the brain compared to intranasal administration. Genetic factors and sex have varying effects on the uptake of the spike protein in different tissues.
NATURE NEUROSCIENCE
(2021)
Article
Virology
Pratima Kumari et al.
Summary: The study demonstrated that SARS-CoV-2 infection can lead to neuroinvasion and encephalitis in K18-hACE2 mice, resulting in mortality. While the highest virus titers were observed in the lungs, high levels of infectious virus were also found in the brains of the infected mice. The severity of the disease in infected mice correlated with peak viral levels in the brain.
Article
Multidisciplinary Sciences
Angela Wahl et al.
Summary: The study suggests that bats may be the source of coronaviruses that can be directly transmitted to humans. Using the LoM model, efficient replication of SARS-CoV, MERS-CoV, SARS-CoV-2, and two SARS-like bat coronaviruses in human lung tissue was demonstrated. Infection with SARS-CoV-2 predominantly targets human lung epithelial cells and induces a sustained inflammatory response. The broad-spectrum antiviral agent EIDD-2801 significantly inhibits SARS-CoV-2 replication in vivo, showing potential for prevention and treatment of COVID-19.
Article
Multidisciplinary Sciences
Junjuan Wang et al.
Summary: This study examined 260 patients with severe COVID-19, showing that most patients presented symptoms within 8 days before admission and a proportion had medical comorbidities. Abnormal blood biochemical results were common upon admission. The mortality rate was 9.6%, with 70.4% of patients discharged.
SCIENTIFIC REPORTS
(2021)
Article
Multidisciplinary Sciences
Dennis Lapuente et al.
Summary: The study demonstrates that priming with systemic mRNA and boosting with intranasal adenoviral vector vaccine in mice induces comprehensive T cell and mucosal immunity. The strategy provides complete protection against SARS-CoV-2 infection in mice after boosting.
NATURE COMMUNICATIONS
(2021)
Article
Immunology
Stefanie Kreutmair et al.
Summary: The immune profiles of severe COVID-19 and non-SARS-CoV-2 pneumonia patients show similarities in some aspects, but pathological immune signatures indicative of T cell exhaustion are exclusive to COVID-19 and linked to impaired virus recognition. Circulating NKT cell frequency was identified as a predictive biomarker for patient outcome.
Article
Virology
Chao Shang et al.
Summary: This study identified SARS-CoV-2-triggered autophagy in animal models and cells, demonstrating that autophagy inhibition suppresses virus replication. The use of a new animal model, mice xenografted with human lung tissues, provided insights into potential therapeutic targets for SARS-CoV-2.
JOURNAL OF VIROLOGY
(2021)
Article
Multidisciplinary Sciences
Rita E. Chen et al.
Summary: Cell culture experiments showed reduced or abrogated neutralizing activity of monoclonal antibodies against SARS-CoV-2 variant strains, but low prophylactic doses of antibody combinations protected against infection in vivo without resistance emergence. Higher doses of several monoclonal antibody cocktails also provided protection against viruses with a B.1.351 spike gene in vivo. Many antibody products with Emergency Use Authorization should therefore retain substantial efficacy against prevailing variant strains of SARS-CoV-2.
Article
Immunology
Meagan M. Jenkins et al.
Summary: During influenza virus infection, lung migratory dendritic cells not only prime CD8(+) T cell responses in the lungs but also migrate to the spleen to initiate cell responses, challenging the current paradigm.
SCIENCE IMMUNOLOGY
(2021)
Review
Immunology
Masood Alam Khan et al.
Summary: NKT cells play a crucial role in immune response, while nanoparticle-based formulations show superior immunoadjuvant potential. Research has shown that NKT cell ligands can play an important role in the development of antiviral vaccines, activating both cell-mediated and humoral immune responses.
Article
Biochemistry & Molecular Biology
Ling Zhang et al.
Summary: The study found evidence supporting that SARS-CoV-2 can cross the blood-brain barrier in transcellular pathways based on experiments in mice and hamsters. The transmission pathway involves disrupted basement membrane without obvious alteration of tight junctions.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2021)
Article
Multidisciplinary Sciences
Jian Zheng et al.
Summary: The COVID-19 pandemic is associated with significant morbidity and mortality. Experimental studies in animals infected with SARS-CoV-2 have revealed severe lung and brain damage, as well as early onset anosmia in mice. Excitingly, infusion of convalescent plasma from recovered patients has shown to protect against lethal disease, though it does not prevent anosmia.
Article
Medicine, Research & Experimental
Wenkun Fu et al.
Summary: This study utilized a humanized mouse model with human lung xenografts to investigate SARS-CoV-2 infection. The results showed that the human lung xenografts closely resembled normal human lung structure, supported efficient replication and spread of SARS-CoV-2, caused severe lung damage, and induced a strong pro-inflammatory response. Treatment with IFN-alpha effectively inhibited viral replication in the lung xenografts. This model proves to be a valuable tool for studying SARS-CoV-2 lung infection pathogenesis and evaluating potential antiviral therapies.
Article
Medicine, General & Internal
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(2020)
Article
Medicine, General & Internal
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE
(2020)
Article
Critical Care Medicine
Xiaobo Yang et al.
Lancet Respiratory Medicine
(2020)
Review
Biochemistry & Molecular Biology
Ying-Ting Wang et al.
TRENDS IN MICROBIOLOGY
(2020)
Article
Medicine, General & Internal
Fei Zhou et al.
Article
Medicine, Research & Experimental
Alessio Mazzoni et al.
JOURNAL OF CLINICAL INVESTIGATION
(2020)
Letter
Biochemistry & Molecular Biology
Achim D. Gruber et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Takuya Sekine et al.
Article
Biochemistry & Molecular Biology
Sarah R. Leist et al.
Article
Biochemistry & Molecular Biology
Carolyn Rydyznski Moderbacher et al.
Article
Virology
Rebecca L. Brocato et al.
JOURNAL OF VIROLOGY
(2020)
Article
Multidisciplinary Sciences
Ludovico Cantuti-Castelvetri et al.
Letter
Biochemistry & Molecular Biology
Li Tan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2020)
Review
Immunology
Sinuhe Hahn et al.
FRONTIERS IN IMMUNOLOGY
(2019)
Article
Biochemistry & Molecular Biology
Mauro Gaya et al.
Review
Microbiology
Jennifer A. Juno et al.
Review
Immunology
Leonard D. Shultz et al.
NATURE REVIEWS IMMUNOLOGY
(2007)
Article
Immunology
V. Hugh Perry et al.
NATURE REVIEWS IMMUNOLOGY
(2007)
Article
Virology
Paul B. McCray et al.
JOURNAL OF VIROLOGY
(2007)
